Advertisement
UK markets closed
  • FTSE 100

    7,895.85
    +18.80 (+0.24%)
     
  • FTSE 250

    19,391.30
    -59.37 (-0.31%)
     
  • AIM

    745.67
    +0.38 (+0.05%)
     
  • GBP/EUR

    1.1634
    -0.0049 (-0.42%)
     
  • GBP/USD

    1.2392
    -0.0047 (-0.37%)
     
  • Bitcoin GBP

    51,802.41
    +654.09 (+1.28%)
     
  • CMC Crypto 200

    1,385.40
    +72.78 (+5.55%)
     
  • S&P 500

    4,977.99
    -33.13 (-0.66%)
     
  • DOW

    37,892.47
    +117.09 (+0.31%)
     
  • CRUDE OIL

    83.07
    +0.34 (+0.41%)
     
  • GOLD FUTURES

    2,408.10
    +10.10 (+0.42%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • HANG SENG

    16,224.14
    -161.73 (-0.99%)
     
  • DAX

    17,737.36
    -100.04 (-0.56%)
     
  • CAC 40

    8,022.41
    -0.85 (-0.01%)
     

Eurobank signs deal with doValue to sell bad loan portfolio notes

FILE PHOTO: View of a Eurobank branch in Athens

ATHENS (Reuters) -Eurobank, one of Greece's four largest lenders, signed a deal with credit servicer doValue to sell a portion of mezzanine and junior notes of a 5.2 billion euro ($6 billion) non-performing loan portfolio securitisation, it said on Monday.

Greek banks are cleaning up their balance sheets from non-performing loans via outright sales and securitisations in an effort to reach single-digit non-performing loan (NPL) ratios next year to bring them close to eurozone averages.

The portfolio of non-performing loans, dubbed project Mexico, has a gross book value of 3.2 billion euros and doValue

will be servicing the sour loans.

ADVERTISEMENT

The transaction is expected to be completed by end-December subject to certain conditions, including the issuance of a ministerial decision to include the Mexico securitisation in the government's Hercules II bad loan reduction scheme.

Eurobank said the non-performing loans of the Mexico secutitisation will be reclassified as 'held for sale' in the third quarter.

Completion of the sale of Mexico notes and the derecognition of Mexico loans will take place in this year's fourth quarter.

The transaction will have no material impact on Eurobank's regulatory capital ratios and its NPE (non-performing exposures) ratio is expected to stand at 7.3%.

Alantra Corporate Portfolio Advisors International advised Eurobank on the sale.

($1 = 0.8633 euros)

(Reporting by Angeliki Koutantou and George Georgiopoulos; Editing by Edmund Blair and Louise Heavens)